- Home
- SLRN vs FINW Comparison
SLRN vs FINW Comparison
Compare SLRN & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRN
- FINW
- Stock Information
- Founded
- SLRN 2020
- FINW 1999
- Country
- SLRN United States
- FINW United States
- Employees
- SLRN N/A
- FINW N/A
- Industry
- SLRN Biotechnology: Pharmaceutical Preparations
- FINW Commercial Banks
- Sector
- SLRN Health Care
- FINW Finance
- Exchange
- SLRN Nasdaq
- FINW Nasdaq
- Market Cap
- SLRN 224.6M
- FINW 182.3M
- IPO Year
- SLRN 2023
- FINW 2021
- Fundamental
- Price
- SLRN $2.34
- FINW $15.14
- Analyst Decision
- SLRN Hold
- FINW Buy
- Analyst Count
- SLRN 5
- FINW 4
- Target Price
- SLRN $9.60
- FINW $20.75
- AVG Volume (30 Days)
- SLRN 970.9K
- FINW 22.3K
- Earning Date
- SLRN 05-12-2025
- FINW 04-30-2025
- Dividend Yield
- SLRN N/A
- FINW N/A
- EPS Growth
- SLRN N/A
- FINW N/A
- EPS
- SLRN N/A
- FINW 0.93
- Revenue
- SLRN N/A
- FINW $69,816,000.00
- Revenue This Year
- SLRN $267.11
- FINW $43.53
- Revenue Next Year
- SLRN N/A
- FINW $21.91
- P/E Ratio
- SLRN N/A
- FINW $16.59
- Revenue Growth
- SLRN N/A
- FINW 8.45
- 52 Week Low
- SLRN $1.85
- FINW $10.02
- 52 Week High
- SLRN $7.25
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- SLRN 47.95
- FINW 37.88
- Support Level
- SLRN $2.17
- FINW $14.41
- Resistance Level
- SLRN $2.32
- FINW $15.17
- Average True Range (ATR)
- SLRN 0.18
- FINW 0.74
- MACD
- SLRN -0.00
- FINW 0.04
- Stochastic Oscillator
- SLRN 33.88
- FINW 32.20
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.